Pillstats
Rx only · Tablet, Film Coated · Oral

Deferasirox

Brands: Jadenu · Deferasirox

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US30 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)614373
US makers9 labelers
Packages45
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 11 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.372$0.744$1.12$1.49Oct 2025Mar 2026Jul 2026
$1.200
Latest avg · Jul 22, 2026
+37%
Since Oct 22, 2025
9
Active US suppliers
40%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

9041.8K2.7K3.6K2025 Q12025 Q22025 Q32025 Q42026 Q1
2.7K
Rx · 2026 Q1
218K
Units dispensed
-13%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Alembic Pharmaceuticals Limitedunknown12SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown6SUPPLYING
Zydus Lifesciences Limitedunknown6SUPPLYING
Ascend Laboratories, LLCunknown6SUPPLYING
NorthStar Rx LLCunknown3SUPPLYING
Camber Pharmaceuticals, Inc.unknown3SUPPLYING
Amneal Pharmaceuticals LLCunknown3SUPPLYING
Novartis Pharmaceuticals Corporationunknown3SUPPLYING
Aurobindo Pharma Limitedunknown3SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.